Effects of landiolol on systemic and cerebral hemodynamics and recovery from anesthesia in patients undergoing craniotomy
- 26 March 2010
- journal article
- research article
- Published by Springer Nature in Journal of Anesthesia
- Vol. 24 (4) , 503-510
Abstract
Maintenance of systemic and cerebral hemodynamics and quick recovery from anesthesia are required for craniotomy. We conducted a prospective randomized study to investigate the effects of continuous infusion of landiolol on hemodynamic responses to various stimuli, changes in systemic and cerebral hemodynamics during anesthesia, and recovery from anesthesia in patients undergoing craniotomy.Keywords
This publication has 21 references indexed in Scilit:
- Effects of a Short-acting β1 Receptor Antagonist Landiolol on Hemodynamics and Tissue Injury Markers in Patients With Subarachnoid Hemorrhage Undergoing Intracranial Aneurysm SurgeryJournal of Neurosurgical Anesthesiology, 2010
- Effects of landiolol, a short-acting beta-1 blocker, on hemodynamic variables during emergence from anesthesia and tracheal extubation in elderly patients with and without hypertensionJournal of Anesthesia, 2009
- Landiolol, a new ultra-short-acting β1-blocker, reduces anaesthetic requirement during sevoflurane/N2O/fentanyl anaesthesia in surgical patientsEuropean Journal of Anaesthesiology, 2009
- Clinical role and efficacy of landiolol in the intensive care unitJournal of Anesthesia, 2008
- The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery diseaseJournal of Clinical Anesthesia, 2007
- Landiolol, an Ultra–Short-Acting β1-Adrenoceptor Antagonist, Does Not Alter the Minimum Alveolar Anesthetic Concentration of Isoflurane in a Swine ModelAnesthesia & Analgesia, 2007
- Landiolol attenuates the cardiovascular response to tracheal intubationJournal of Anesthesia, 2005
- The Short-Acting β1-Adrenoceptor Antagonists Esmolol and Landiolol Suppress the Bispectral Index Response to Tracheal Intubation During Sevoflurane AnesthesiaAnesthesia & Analgesia, 2005
- Electrophysiologic, Cardiohemodynamic and β-Blocking Actions of a New Ultra-Short-Acting β-Blocker, ONO-1101, Assessed by the In Vivo Canine Model in Comparison with EsmololJournal of Cardiovascular Pharmacology, 1999
- Development of a Highly Cardioselective Ultra Short-Acting .BETA.-Blocker, ONO-1101.Chemical and Pharmaceutical Bulletin, 1992